Jacobs Levy Equity Management 13F: Cuts GL Stake by $34M

Jacobs Levy Equity Management Reduces Stake in Globe Life Inc.

Jacobs Levy Equity Management pared back its holdings in Globe Life Inc. NYSE:GL, according to a recent Form 13F filing with the Securities and Exchange Commission. The filing reflects holdings as of May 15, 2026, and may not represent the fund's current position today.

Position Adjustments in Globe Life Shares

The fund cut its position by 191,761 shares during the period, marking a 24.8% decrease from its previous count of 770,217 shares. Jacobs Levy Equity Management ended the reporting period with 578,456 shares of the insurer. The remaining stake carried a reported value of about $103.4 million based on the filing data.

Globe Life Stock Price Levels

Shares of Globe Life trade around $178.68. The company carries a market capitalization of $13.2 billion and a price-to-earnings ratio of 11.4. The stock has moved between a 52-week low of $127.85 and a 52-week high of $191.55.

Recent Earnings Performance

For the recent reporting period, Globe Life reported $6.19 billion in revenue with a revenue growth rate of 8.0%. The company posted earnings of $15.04 per share alongside a net margin of 19.6% and a return on equity of 20.9%. The company's next earnings report is scheduled for October 21, 2026.

Dividend Payout Details

The company pays an annual dividend of $1.32 per share, translating to a dividend yield of 0.76%. The payout is backed by a dividend payout ratio of 7.9%.

Insider Buying and Selling at Globe Life Inc.

Company insiders have been active in the open market recently. On June 30, 2026, EVP and Chief Administrative Officer Dolores Skarjune acquired 1,850 shares at $103.23 and disposed of 1,850 shares at $179.18 on the same day. Earlier, EVP and Chief Talent Officer Rebecca Zorn acquired 2,000 shares on June 18, 2026, and Co-Chairman and CEO Frank Svoboda transacted 10,000 shares on June 11, 2026.

Analysts Set New Price Targets

Wall Street firms continue to monitor the stock with various updates. On October 15, 2026, JP Morgan maintained its overweight rating and raised its price target to $195.00 from $193.00. Wells Fargo kept an overweight rating on October 12, 2026, lifting its target to $191.00. Morgan Stanley maintained an overweight rating on October 5, 2026, adjusting its target to $197.00. Overall, the stock holds a consensus target mean price of $193.91.

About Globe Life Inc.

Headquartered in McKinney, Texas, Globe Life provides life and supplemental health insurance products to families across the United States through various agency and direct channels. The company operates through life and health segments to serve middle-income households.

What to Watch at Globe Life Inc.

Investors will look toward the company's upcoming earnings release on October 21, 2026, for further financial updates. Institutional ownership figures will continue to update in future SEC filings, though this report captures past positioning.